Delivery Order SPE2DB22D2206-SPE2DB23FKR76
Award Date 9/29/23
Potential Completion Date 10/2/23
Potential Value $13K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Detrol LA 2 mg capsules. The contract, valued at $30,160.75, is a delivery order awarded under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,768.21, is for the delivery of Detrol LA 2 mg capsules. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 19, 2023. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,677.82 firm fixed-price contract is for the supply of Detrol LA 4 mg capsules. The contract has a period of performance ending on March 31, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,995.90 firm-fixed-price delivery order is for the supply of DETROL LA 2 MG CAPSULE 90S, a prescription medication. The contract has an ultimate completion date of May 8, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,605.17 firm fixed-price delivery order is for DETROL LA 4 MG CAPSULE 500S, a pharmaceutical product. The contract has a completion date of September 26, 2023 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as...
- This federal contract award to AmerisourceBergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider, is a delivery order valued at $6,995.48 for the supply of Detrol LA 4 mg capsules. The award was made by the Defense Logistics Agency (DLA), a civilian defense agency that serves as a critical supplier of medical and pharmaceutical products to federal agencies. The contract is a firm fixed-price delivery order with a completion date of September 15, 2023. It is not...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Detrol LA 4 mg capsules. The contract, valued at $22,016.68, is a firm fixed-price delivery order that has a completion date of May 16, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc., which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,518.99 firm fixed-price delivery order is for the supply of DETROL LA 2 MG CAPSULE 90S, a medication used to treat overactive bladder. The contract has an ultimate completion date of May 25, 2023 and does not have any set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $8,313.25, is for the delivery of Detrol LA 2 mg capsules and has an ultimate completion date of January 30, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,058.00, is for the delivery of Detrol LA 4 mg capsules. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FKR76Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Detrol LA 2 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $12,768.40 and a completion date of October 2, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Generated 5/12/25, 9:59 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 9/29/23 |